Laboratory prediction of the requirement for renal replacement in acute falciparum malaria

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Hanson, Josh ^a,b   Hasan, Md Mahtab ^c   Royakkers, Annick A ^d   Alam, Shamsul ^c   Charunwatthana, Prakaykaew ^b   Maude, Richard J ^b,e   Douthwaite, Sam T ^b   Yunus, Emran ^c   Mantha, Murty L ^a   Schultz, Marcus J ^d   Faiz, M ^f   White, Nicholas J ^b,e   Day, Nicholas P ^b,e   Dondorp, Arjen M ^b,e  

^a CAIRNS BASE HOSPITAL   (Australia)

^b MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^c CHITTAGONG MEDICAL COLLEGE HOSPITAL   (Bangladesh)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f SIR SALIMULLAH MEDICAL COLLEGE   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE; LEVAMISOLE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SODIUM; UREA;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BRAIN MALARIA; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DISEASE TRANSMISSION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MORTALITY; OSMOLALITY; RENAL FAILURE INDEX; RENAL REPLACEMENT THERAPY; RENAL SYSTEM PARAMETERS; SODIUM URINE LEVEL; TREATMENT DURATION; CHEMISTRY; KIDNEY FAILURE; MIDDLE AGED; PLASMA; PROGNOSIS; PROSPECTIVE STUDY; URINE;

ADULT; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMA; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RENAL REPLACEMENT THERAPY; URINE;

EID: 79961010189     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-217     Document Type: Article

References (29)

1. Artesunate versus quinine for treatment of severe falciaprum malaria: a randomized trial. Dondorp A, Nosten F, Stepniewska K, Day N, White N, South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group, Lancet 2005 366 717 725 16125588 (Pubitemid 41207233)
2. Severe falciparum malaria. World Health Organization, Trans R Soc Trop Med 2000 94 1
3. Acute renal failure in patients with severe falciparum malaria. Trang TT, Phu NH, Vinh H, Hien TT, Cuong BM, Chau TT, Mai NT, Waller DJ, White NJ, Clin Infect Dis 1992 15 874 80 10.1093/clind/15.5.874 1445988
4. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. Phu NH, Hien TT, Mai NT, Chau TT, Chuong LV, Loc PP, Winearls C, Farrar J, White N, Day N, N Engl J Med 2002 347 895 902 10.1056/NEJMoa020074 12239258
5. A quantitative ultrastructural study of renal pathology in fatal Plasmodium falciparum malaria. Nguansangiam S, Day NP, Hien TT, Mai NT, Chaisri U, Riganti M, Dondorp AM, Lee SJ, Phu NH, Turner GD, White NJ, Ferguson DJ, Pongponratn E, Trop Med Int Health 2007 12 1037 50 10.1111/j.1365-3156.2007. 01881.x 17875015 (Pubitemid 47414937)
6. Malarial nephropathy. Eiam Ong S, Sem Nephrol 2003 23 21 33 10.1053/snep.2003.50002 (Pubitemid 36164466)
7. Diagnosis and treatment of acute tubular necrosis. Esson ML, Schrier RW, Ann Intern Med 2002 137 744 752 12416948 (Pubitemid 35265319)
8. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Carvounis CP, Nisar S, Guro-Razuman S, Kidney Int 2002 62 2223 2229 10.1046/j.1523-1755.2002.00683.x 12427149 (Pubitemid 35366179)
9. Acute renal failure in hospitalized patients. Nally JV, Cleve Clin J Med 2002 69 569 574 10.3949/ccjm.69.7.569 12109642
10. The FeNa test. Use in the differential diagnosis of acute renal failure. Espinel CH, JAMA 1976 236 579 581 10.1001/jama.236.6.579 947239
11. Urinary diagnostic indices in acute renal failure: a prospective study. Miller TR, Anderson RJ, Linas SL, Henrich WL, Berns AS, Gabow PA, Schrier RW, Ann Intern Med 1978 89 47 50 666184 (Pubitemid 8390144)
12. Urinary biochemistry in experimental septic acute renal failure. Langenberg C, Wan L, Bagshaw SM, Egi M, May CN, Bellomo R, Nephrol Dial Transplant 2006 21 3389 3397 10.1093/ndt/gfl541 16998215 (Pubitemid 44817086)
13. Treatment of acute renal failure. Star RA, Kidney Int 1998 54 1817 1831 10.1046/j.1523-1755.1998.00210.x 9853246 (Pubitemid 28533609)
14. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P, Lancet 2005 365 1231 1238 10.1016/S0140-6736(05)74811-X 15811456 (Pubitemid 40469655)
15. NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A, Am J Kidney Dis 2009 54 1012 1024 10.1053/j.ajkd.2009.07.020 19850388
16. N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial. Charunwatthana P, Abul Faiz M, Ruangveerayut R, Maude RJ, Rahman MR, Roberts LJ, Moore K, Bin Yunus E, Hoque MG, Hasan MU, Lee SJ, Pukrittayakamee S, Newton PN, White NJ, Day NP, Dondorp AM, Crit Care Med 2009 37 516 522 10.1097/CCM.0b013e3181958dfd 19114891
17. WHO guidelines for the management of severe malaria. 2000 http://www.rollbackmalaria.org/docs/hbsm.pdf
18. WHO guidelines for the treatment of malaria. 2010 http://www.who.int/ malaria/publications/atoz/9789241547925/en/index.html
19. Kidney function estimating equations: where do we stand? Coresh J, Stevens LA, Curr Opin Nephrol Hypertens 2006 15 276 284 10.1097/01.mnh. 0000222695.84464.61 16609295
20. Assessing kidney function-measured and estimated glomerular filtration rate. Stevens LA, Coresh J, Greene T, Levey AS, NEJM 2006 354 2473 2483 10.1056/NEJMra054415 16760447 (Pubitemid 43855050)
21. Prediction of creatinine clearance from plasma creatinine. Cockcroft DW, Gault MH, Nephron 1976 16 31 41 10.1159/000180580 1244564
22. A simple score to predict the outcome of severe malaria in adults. Hanson J, Lee SJ, Mohanty S, Faiz MA, Anstey NM, Charunwatthana P, Yunus EB, Mishra SK, Tjitra E, Price RN, Rahman R, Nosten F, Htut Y, Hoque G, Hong Chau TT, Hoan Phu N, Hien TT, White NJ, Day NP, Dondorp AM, Clin Infect Dis 2010 50 679 685 10.1086/649928 20105074
23. Clinical usefulness of novel biomarkers for the detection of acute kidney injury following elective cardiac surgery. Che M, Xie B, Xue S, Dai H, Qian J, Ni Z, Axelsson J, Yan Y, Nephron Clin Pract 2010 115 66 72 10.1159/000286352
24. Changes in protein turnover and resting energy expenditure after treatment of malaria in Gambian children. Berclaz PY, Benedek C, Jequier E, Schutz Y, Pediatr Res 1996 39 401 409 10.1203/00006450-199603000-00005 8929858 (Pubitemid 26070831)
25. Meta-analysis: effectiveness of drugs for preventing contrast- induced nephropathy. Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC, Ann Intern Med 2008 148 284 294 18283206 (Pubitemid 351665489)
26. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON). Komisarof JA, Gilkey GM, Peters DM, Koudelka CW, Meyer MM, Smith SM, Crit Care Med 2007 35 435 441 10.1097/01.CCM.0000253816. 83011.DB 17205018 (Pubitemid 46148533)
27. Primary prevention of acute renal failure in the critically ill. Kellum JA, Leblanc M, Gibney RT, Tumlin J, Lieberthal W, Ronco C, Curr Opin Crit Care 2005 11 537 541 16292056 (Pubitemid 41697324)
28. Adverse reactions to levamisole. Symoens J, Veys E, Mielants M, Pinals R, Cancer Treat Rep 1978 62 1721 1730 365327 (Pubitemid 9132928)
29. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized controlled trials? Lord SJ, Irwig L, Simes RJ, Ann Intern Med 2006 144 850 855 16754927 (Pubitemid 46780618)